Evidence map›Paper›PMID 42129122›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Using Luciferase Reporter Cells to Assess the Effects of MIF Inhibitors on NF-κB Activation.

Sarah Little, Katie Treasure, Srinivasan Jayashree, James Harris

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sarah LittleBiomedical Manufacturing, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Clayton, VIC, Australia.
Katie TreasureDepartment of Nutrition, Dietetics and Food, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC, Australia.
Srinivasan JayashreeBiomedical Manufacturing, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Clayton, VIC, Australia.
James HarrisBiomedical Manufacturing, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Clayton, VIC, Australia. jim.harris@csiro.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nuclear factor-κB (NF-κB) is a family of transcription factors that regulate cellular responses to a variety of stimuli, including stress, ultraviolet radiation, microbial components, growth factors, and cytokines. Assessment of NF-κB activation can be investigated by measuring the expression of NF-κB-responsive genes and their products, typically using polymerase chain reaction (PCR) and/or immunoblotting for protein. Alternatively, translocation of NF-κB subunits from the cytosol to the nucleus can be measured using microscopy techniques. However, these methods can be complex and time-consuming. Luciferase-based reporter systems allow for rapid detection of gene expression. This chapter details the use of myeloid cells stably transfected with NF-κB-inducible luciferase reporter constructs to assess the effects of inflammatory stimuli and MIF inhibitors on NF-κB activation.

Indexed as

Genes, ReporterIntramolecular OxidoreductasesLuciferasesMacrophage Migration-Inhibitory FactorsNF-kappa BCell LineGene Expression RegulationHumansSignal TransductionIntramolecular OxidoreductasesLuciferasesMacrophage Migration-Inhibitory FactorsNF-kappa BCytokinesInflammationMacrophage migration inhibitory factorSmall molecule inhibitorsTHP-1

Identifiers

PMID42129122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.